We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Plans Public Workshop to Evaluate Studies of Abuse-Deterrent Opioid Use
FDA Plans Public Workshop to Evaluate Studies of Abuse-Deterrent Opioid Use
The FDA is planning a public workshop in July to evaluate the impact of abuse-deterrent formulations of opioid painkillers, and to find ways to better inform the agency’s regulatory approach, following recently renewed calls to action.